University of Ioannina
Μελέτη της μεταγωγής παθογενετικών σημάτων μέσω της ενδοκυττάριας κινάσης Tpl2 στην πειραματική φλεγμονώδη εντεροπάθεια
Abstract
dc:descriptionTumor Necrosis Factor (TNF) plays a central role in Inflammatory Bowel Disease (IBD) pathogenesis. TnfΔARE/+ mice, which chronically overproduce TNF, spontaneously develop IBD pathology. Ιt has been shown that in tnfΔARE/+ mice, the genetic ablation of Tpl2 kinase leads to a severely delayed onset of IBD pathology. Aim of this work is a further study of the molecular and cellular pathways implicated in IBD pathogenesis in tnfΔARE/+ mice. At the cellular level, we studied the role of intestinal epithelial cells (IECs) in IBD pathogenesis as a cellular source and as a cellular target of TNF. At the molecular level, we studied the role of Tpl2 kinase in IBD pathogenesis in a tissue specific approach in order to identify the cell types where Tpl2 acts as a mediator of pathogenic signals. In order to study the role of IECs as a specific cellular source of TNF in the intestinal mucosa, we generated mice overproducing TNF specifically by IECs. In order to study the effects of TNF specifically on IECs, in vivo, we generated mice expressing TNFR-I selectively in IECs. For the tissue-specific study of the role of Tpl2 we generated tpl2 conditional knock-out mice. Our results show that TNF overproduction by IECs is a condition sufficient for the development of IBD pathology and leads to an early activation of the underlying mesenchymal cells of the gut, the intestinal myofibroblasts. Concerning the role of IECs as a cellular target of TNF , we show that acute exogenous TNF administration leads to IEC apoptosis in a direct manner via epithelial TNFR-I, whereas the chronic selective targeting of IECs by TNF in tnfΔARE/+ mice is not sufficient to lead to the development of IBD pathology. At the molecular level, we show that in tnfΔARE/+ mice, the specific deletion of Tpl2 in myeloid lineage cells or in IECs doesn’t affect the development of IBD pathology. In contrast, the specific deletion of Tpl2 in mesenchymal cells leads to a trend of delayed onset of disease. These results show that Tpl2 may be an important molecular mediator of early pathogenic signals in tnfΔARE/+ mice in the intestinal myofibroblasts.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Roulis, Manolis
- Ρούλης, Εμμανουήλ
Subjects
dc:subject × 20- Φλεγμονώδεις εντεροπάθειες
- Ιδιοπαθείς Φλεγμονώδεις Παθήσεις του Εντέρου (ΙΦΕΝ, ΙΦΠΕ)
- Νόσος του Crohn
- Επιθηλιακά Κύτταρα Εντέρου
- MAP κινάσες
- Υποδοχέας του TNF
- Παράγοντας Νέκρωσης των Όγκων
- Μυοϊνοβλάστες
- Inflammatory bowel diseases (IBD)
- Crohn's disease
- Tumor necrosis factor (TNF)
- Intestinal Epithelial Cells
- Tumor Progression Locus-2 (Tpl2)
- TNF receptor I (TNFR-I, p55)
- Map kinases
- Myofibroblasts
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17445